Barclays Maintains Equal-Weight on Qiagen, Lowers Price Target to $38

Benzinga Newsdesk www.benzinga.com Neutral 54.3%

Neg 0% Neu 54.3% Pos 0%

Barclays analyst Luke Sergott maintains Qiagen (NYSE:QGEN) with a Equal-Weight and lowers the price target from $44 to $38.